Ignite Creation Date:
2025-12-24 @ 6:46 PM
Ignite Modification Date:
2026-02-25 @ 10:04 PM
Study NCT ID:
NCT03786757
Status:
UNKNOWN
Last Update Posted:
2018-12-26
First Post:
2018-12-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ)
Sponsor:
RenJi Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Cardiology-LVT Ⅱ
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None